Stay updated with breaking news from Helmut salih. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
T-cell activator offers protection against coronaviruses in immunocompromised cancer patients medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.
All patients in a rectal cancer drug trial were in remission after six months. Experts say it's 'revolutionary' but bigger, more diverse studies are needed. ....
Share this article Share this article BRAUNSCHWEIG, Germany, March 16, 2021 /PRNewswire/ CORAT Therapeutics GmbH obtained the regulatory approval as well as the favorable opinion from the central ethics committee to conduct the clinical phase Ib/II trial with its antibody COR-101 against COVID-19. COR-101 is a neutralizing human antibody that binds to the receptor binding domain (RBD) of the spike protein of SARS-CoV-2 and is endowed with a unique structural design. It aims to improve the treatment situation of hospitalized COVID-19 patients with moderate to severe disease, a patient group which currently cannot be treated appropriately due to the lack of effective medication. The innovative safety design of COR–101 prevents any Fc-gamma receptor binding and avoids the risk of antibody dependent enhancement (ADE) of disease. The antibody was isolated from convalescent patients and was developed with an accelerated development strategy under guidance of the German regul ....
CORAT Therapeutics GmbH obtained regulatory authorization for clinical phase Ib/II trial with the SARS-CoV-2 neutralizing human antibody COR-101 prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.